STX
50
-2
XYL
39
-2
AVGO
30
-5
TDC
73
2
GE
65
-6
KHC
15
-2
CB
55
2
KO
42
-2
MDT
57
-2
DFS
64
-3
AAP
44
2
ED
43
-2
TAP
60
-4
LLY
37
-7
COF
59
-4
V
66
-4
IRM
39
-3
HOG
35
2
HUM
46
-2
ES
29
3
STX
50
-2
XYL
39
-2
AVGO
30
-5
TDC
73
2
GE
65
-6
KHC
15
-2
CB
55
2
KO
42
-2
MDT
57
-2
DFS
64
-3
AAP
44
2
ED
43
-2
TAP
60
-4
LLY
37
-7
COF
59
-4
V
66
-4
IRM
39
-3
HOG
35
2
HUM
46
-2
ES
29
3
Financhill
Back

Ligand Pharmaceuticals Quote, Financials, Valuation and Earnings

"This Changes Everything" - Trump Hands Millions Massive IRS Gift

Learn More Here
Buy
56

LGND
Ligand Pharmaceuticals

Last Price:
112.58
Seasonality Move:
10.42%

7 Day Trial

ALL ACCESS PASS

$ 7

Trump wins! Dow to 75,000? Details here

See the explosive "Document 20" details here.

Ligand Pharmaceuticals Price Quote

$112.58
-2.87 (-2.49%)
(Updated: November 15, 2024 at 10:25 AM ET)

Ligand Pharmaceuticals Key Stats

Buy
56
Ligand Pharmaceuticals (LGND) is a Buy
Day range:
$114.39 - $125.76
52-week range:
$55.30 - $129.90
Dividend yield:
0%
P/E ratio:
39.27
P/S ratio:
13.68
P/B ratio:
2.59%
Volume:
135.1K
Avg. volume:
118.7K
1-year change:
104.44%
Market cap:
$2.2B
Revenue:
$131.3M
EPS:
$2.51

How Much Does Ligand Pharmaceuticals Make?

Is Ligand Pharmaceuticals Growing As A Company?

Ligand Pharmaceuticals Stock Price Performance

What Is Ligand Pharmaceuticals 52-Week High & Low?

Ligand Pharmaceuticals Price To Free Cash Flow

Is It Risky To Buy Ligand Pharmaceuticals?

Is Ligand Pharmaceuticals Cash Flow Positive?

  • What Is LGND Cash Flow From Operations?
    Cash flow from operations (TTM) is $76.6M
  • What Is Ligand Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $82.1M
  • What Is Ligand Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$115.3M

Ligand Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    LGND return on invested capital is 5.97%
  • What Is Ligand Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is 5.27%
  • What Is LGND Return On Equity?
    ROE is a measure of profitability and is 5.97%

Ligand Pharmaceuticals Earnings Date & Stock Price

Ligand Pharmaceuticals Competitors

Ligand Pharmaceuticals Dividend Yield

Ligand Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 36.66%
Revenue: 57.64% 27.61%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 138.38
Upside from Last Price: 19.86%

Major Shareholders

  • How many LGND shares are owned by institutional investors?
    29.9M LGND shares are owned by institutional investors
  • How many LGND shares are owned by insiders?
    2M LGND shares are owned by insiders